CSPC Pharma Surges Over 8% Amid Mixed Analyst Ratings
CSPC Pharmaceutical Group (1093.HK) surged over 8% during regular trading hours, currently trading at HK$7.49. The stock has seen a significant increase in trading volume, reaching 126.92 million shares, with a turnover of HK$925.21 million.
Recent news highlights include the company's Q1 2026 performance report, which showed a net profit of RMB 860 million, a year-on-year decrease of 41.8%, and revenue of RMB 6.465 billion, down 7.8% year-on-year. Analysts have mixed views, with some maintaining a 'Buy' rating and others expressing concerns over policy risks and declining licensing fee income.
Source: HK Stock Market Update The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments